HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Bacterial Infections D001424 21 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Alzheimer Disease D000544 76 associated lipids
Adenocarcinoma D000230 166 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Bradley G et al. The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma. 2007 Br. J. Cancer pmid:17437012
Beau-Faller M et al. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. 2009 Br. J. Cancer pmid:19293811
Berney DM et al. Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. 2009 Br. J. Cancer pmid:19293807
Kawanishi H et al. Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. 2007 Br. J. Cancer pmid:17579624
Couvelard A et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. 2005 Br. J. Cancer pmid:15558070
Kupryjańczyk J et al. Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. 2003 Br. J. Cancer pmid:12644821
Mekenkamp LJ et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. 2010 Br. J. Cancer pmid:20551951
Shetty G et al. Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. 2006 Br. J. Cancer pmid:16622450
Ishikawa K et al. Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. 2008 Br. J. Cancer pmid:18506187
Bilim V et al. Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. 2009 Br. J. Cancer pmid:19920820
Scott IS et al. A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia. 2006 Br. J. Cancer pmid:16622441
Trinh XB et al. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. 2009 Br. J. Cancer pmid:19240722
Tang Z et al. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. 2008 Br. J. Cancer pmid:19238632
Buggy Y et al. Overexpression of the Ets-1 transcription factor in human breast cancer. 2004 Br. J. Cancer pmid:15365563
Liu J et al. Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts. 2007 Br. J. Cancer pmid:17519901
Baldewijns MM et al. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. 2007 Br. J. Cancer pmid:17505508
Suzuki S et al. MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer. 2008 Br. J. Cancer pmid:18594524
Aoyagi Y et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. 2004 Br. J. Cancer pmid:15365564
Tajima Y et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. 2004 Br. J. Cancer pmid:15354218
Pattje WJ et al. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. 2010 Br. J. Cancer pmid:20502457
Kim MS et al. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. 2008 Br. J. Cancer pmid:18392055
Moniaux N et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. 2008 Br. J. Cancer pmid:18392050
Weinlich G et al. Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. 2006 Br. J. Cancer pmid:16508630
Shrout J et al. beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients. 2008 Br. J. Cancer pmid:18506145
Andersen CL et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. 2009 Br. J. Cancer pmid:19156145
Tomlinson VA et al. Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus. 2007 Br. J. Cancer pmid:17437010
de Micco C et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. 2008 Br. J. Cancer pmid:18212751
Sakamoto A et al. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours. 2004 Br. J. Cancer pmid:15266333
McArdle PA et al. The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. 2004 Br. J. Cancer pmid:15266325
Gaballah K et al. The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues. 2009 Br. J. Cancer pmid:19623179
Kazama S et al. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. 2006 Br. J. Cancer pmid:16404429
Arnould L et al. Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? 2006 Br. J. Cancer pmid:16404427
Went P et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. 2006 Br. J. Cancer pmid:16404366
Bingle L et al. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. 2006 Br. J. Cancer pmid:16404363
Ben-Izhak O et al. TUNEL - an efficient prognosis predictor of salivary malignancies. 2007 Br. J. Cancer pmid:17325701
Zou L et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. 2007 Br. J. Cancer pmid:17940506
Hettiaratchi A et al. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. 2007 Br. J. Cancer pmid:17311017
Heng B et al. Human papilloma virus is associated with breast cancer. 2009 Br. J. Cancer pmid:19724278
Campbell L et al. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. 2008 Br. J. Cancer pmid:18283322
Fenton BM et al. Zonal image analysis of tumour vascular perfusion, hypoxia, and necrosis. 2002 Br. J. Cancer pmid:12087474
Mc Cormack O et al. Growth arrest-specific gene 6 expression in human breast cancer. 2008 Br. J. Cancer pmid:18283315
Brown NJ et al. Fibrinogen E fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. 2002 Br. J. Cancer pmid:12087471
Bilim V et al. Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis. 2008 Br. J. Cancer pmid:18283311
Clemons MJ et al. Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours. 2002 Br. J. Cancer pmid:12087469
Slade MJ et al. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. 2009 Br. J. Cancer pmid:19034279
Pazgal I et al. Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma. 2002 Br. J. Cancer pmid:12087465
van't Land B et al. Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. 2002 Br. J. Cancer pmid:12085266
Hong AM et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. 2010 Br. J. Cancer pmid:20959828
Yun JP et al. Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. 2007 Br. J. Cancer pmid:17245342
Bhagavathula N et al. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. 2005 Br. J. Cancer pmid:16278666
Chou SC et al. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. 2004 Br. J. Cancer pmid:14760391
Reitsamer R et al. 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up. 2004 Br. J. Cancer pmid:15083184
Garcia S et al. c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. 2007 Br. J. Cancer pmid:17242702
Weigelt B et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. 2004 Br. J. Cancer pmid:15083181
Olivier RI et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. 2004 Br. J. Cancer pmid:15083174
Yao M et al. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. 2004 Br. J. Cancer pmid:14760389
Sriraksa R et al. CpG-island methylation study of liver fluke-related cholangiocarcinoma. 2011 Br. J. Cancer pmid:21448164
Preuss SF et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. 2008 Br. J. Cancer pmid:18212752
Bradley G et al. Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. 2010 Br. J. Cancer pmid:20859287
Page K et al. Detection of HER2 amplification in circulating free DNA in patients with breast cancer. 2011 Br. J. Cancer pmid:21427727
Duanmu J et al. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy. 2011 Br. J. Cancer pmid:21427724
Koumakpayi IH et al. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. 2010 Br. J. Cancer pmid:20216540
Bruynzeel AM et al. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. 2007 Br. J. Cancer pmid:17325706
Bluff JE et al. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. 2009 Br. J. Cancer pmid:19623180
Hamaguchi T et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. 2005 Br. J. Cancer pmid:15785749
Mizukami Y et al. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18841157
Koga F et al. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. 2003 Br. J. Cancer pmid:12618884
Zheng HC et al. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. 2006 Br. J. Cancer pmid:17088917
Deans DA et al. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. 2006 Br. J. Cancer pmid:17088911
Franc B et al. Histological validation of diagnoses of thyroid cancer among adults in the registries of Belarus and the Ukraine. 2003 Br. J. Cancer pmid:14647144
Sheach LA et al. Androgen-related expression of G-proteins in ovarian cancer. 2009 Br. J. Cancer pmid:19623182
Negishi T et al. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. 2006 Br. J. Cancer pmid:16909136
Ord JJ et al. Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma. 2005 Br. J. Cancer pmid:15928663
Debergh I et al. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. 2010 Br. J. Cancer pmid:20125158
Milde-Langosch K et al. Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer. 2005 Br. J. Cancer pmid:15928662
Cellai C et al. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. 2006 Br. J. Cancer pmid:16721373
Vlahovic G et al. Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. 2006 Br. J. Cancer pmid:17003785
Ma S et al. O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. 2003 Br. J. Cancer pmid:14562026
Debrock G et al. A phase II trial with rosiglitazone in liposarcoma patients. 2003 Br. J. Cancer pmid:14562008
Sarbia M et al. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus. 2007 Br. J. Cancer pmid:17940507
Lujan B et al. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. 2010 Br. J. Cancer pmid:20664595
Dufresne A et al. Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. 2010 Br. J. Cancer pmid:20664593
Lau ST et al. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. 2010 Br. J. Cancer pmid:20068565
Cellai I et al. In vivo effects of rosiglitazone in a human neuroblastoma xenograft. 2010 Br. J. Cancer pmid:20068562
Larsson A et al. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. 2011 Br. J. Cancer pmid:21829192
Mori N et al. Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer. 2010 Br. J. Cancer pmid:20664599
Nosho K et al. Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. 2005 Br. J. Cancer pmid:15785755
Matsumoto N et al. Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma. 2003 Br. J. Cancer pmid:12915883
Ajisaka H and Miwa K Micrometastases in sentinel nodes of gastric cancer. 2003 Br. J. Cancer pmid:12915877
MacGrogan G et al. DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer. 2003 Br. J. Cancer pmid:12915875
Nakase Y et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. 2005 Br. J. Cancer pmid:15685235
Alazawi W et al. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. 2004 Br. J. Cancer pmid:15545968
Seenath MM et al. Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer. 2008 Br. J. Cancer pmid:18648372
Modjtahedi H et al. Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10. 2012 Br. J. Cancer pmid:22315050
Jekimovs CR et al. Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals. 2005 Br. J. Cancer pmid:15700044
te Velde EA et al. Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. 2005 Br. J. Cancer pmid:15700042
Roka F et al. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. 2005 Br. J. Cancer pmid:15700039
Gerber SA et al. Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. 2003 Br. J. Cancer pmid:12778077
Wagenaar-Miller RA et al. Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. 2003 Br. J. Cancer pmid:12778076
Tonetti DA et al. Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. 2003 Br. J. Cancer pmid:12778068